Skip to main content
Log in

S. aureus costs higher for methicillin-susceptible infections

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2014 US dollars

Reference

  • Klein EY, et al. National Costs Associated with Methicillin-susceptible and Methicillin-resistant S. aureus Hospitalizations in the United States, 2010-2014. Clinical Infectious Diseases : 12 May 2018. Available from: URL: http://doi.org/10.1093/cid/ciy399

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

S. aureus costs higher for methicillin-susceptible infections. PharmacoEcon Outcomes News 804, 2 (2018). https://doi.org/10.1007/s40274-018-4966-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4966-3

Navigation